Background: Dysphagia with subsequent aspiration occurs in up to 60% of acute respiratory failure (ARF) survivors. Accurate bedside tests for aspiration can reduce aspiration-related complications while minimizing delay of oral nutrition. In a cohort of ARF survivors, we determined the accuracy of the bedside swallowing evaluation (BSE) and its components for detecting aspiration. Methods: Patients who were extubated after at least 24 hours of mechanical ventilation were eligible for enrollment. Within 3 days of extubation, patients underwent comprehensive BSE including 3-oz water swallowing test (3-WST), followed by a criterion standard test for aspiration, flexible endoscopic evaluation of swallowing (FEES). Results: Forty-five patients were included in the analysis. Median patient age was 55 years (interquartile range, 47-65). Median duration of mechanical ventilation was 3.3 days (interquartile range 1.8-6.0). Fourteen patients (31%) aspirated on FEES. Physical examination findings on BSE and abnormal swallowing during trials of different consistencies were variably associated with aspiration. Compared with FEES, the 3-WST yielded a sensitivity of 77% (95% confidence interval [CI], 50%-92%), specificity of 65% (95% CI, 47%-79%), and an area under the receiver operating characteristic curve (AUC) of 0.71; a speech language pathologist's recommendation for altered diet yielded a sensitivity of 86% (95% CI, 60%-96%), a specificity of 52% (95% CI, 35%-68%), and an AUC of 0.69; an speech language pathologist's recommendation for nil per os (nothing by mouth) yielded a sensitivity of 50% (95% CI, 27%-73%), a specificity of 94% (95% CI, 79%-98%), and an AUC of 0.72. Conclusions: The BSE and its components, including the 3-WST, demonstrated variable accuracy for aspiration in survivors of ARF. Investigation to determine the optimal noninvasive test for aspiration in ARF survivors is warranted. Clinical trials registration: ClinicalTrials.gov identifier: NCT02363686, Aspiration in Acute Respiratory Failure Survivors
Background
For the 455 000 survivors of acute respiratory failure (ARF) each year, aspiration is a devastating complication that can develop after initiating oral nutrition [1] . Previous studies have shown that up to 60% of ARF survivors are at risk for aspiration after extubation. Up to 25% aspirate "silently," without signs on clinical examination [2] [3] [4] [5] [6] [7] [8] . Aspiration is associated with pneumonia, feeding tube and tracheostomy placement, longer intensive care unit (ICU) and hospital stay, and increased hospital mortality [9] [10] [11] [12] [13] [14] [15] [16] . However, delaying oral nutrition is associated with prolonged enteral tube feeding and increased health-related costs [17] . The ability to easily and accurately diagnose aspiration in ARF survivors could minimize complications of aspiration while limiting unnecessary delay of oral feeding.
In most hospitals, speech and language pathologists (SLPs) determine when ARF survivors can resume oral feeding [18] . Speech language pathologist commonly use bedside assessments to provide feeding recommendations in this population [18] . The tools used vary between hospitals and SLPs, from simple screening examinations like the 3-oz water swallowing test , to comprehensive bedside swallowing evaluations (BSEs). Bedside swallowing evaluation is a history and physical examination followed by assessment of the patient's ability to swallow boluses of different consistencies, and may include tools like 3-WST. Speech and language pathologists do not routinely perform criterion standard tests such as videofluoroscopic swallow study (VFSS) or flexible endoscopic evaluation of swallowing (FEES) [18] . This is partially due to concerns about safely transporting critically ill patients to radiology for VFSS and lack of equipment or expertise for FEES [18] .
Previous reports have examined the accuracy of BSE to detect aspiration. However, those studies focused on patients recovering from stroke or included a heterogeneous population. None focused exclusively on ARF survivors. Suggested mechanisms for aspiration after mechanical ventilation include "unlearning" of muscle memory, residual sedative medication effects, and injury to the mucosa or peripheral nerves from the endotracheal tube [8, [19] [20] [21] [22] [23] . Because of differing mechanisms of aspiration in other populations, some predictive components of BSE may not apply to ARF survivors [24] [25] [26] [27] . In a cohort of ARF survivors, we evaluated the accuracy of the following beside tests to detect aspiration: the BSE physical examination, BSE trials of different consistencies, 3-WST, and SLP recommendations based on the overall BSE. We used FEES as the criterion standard assessment of aspiration.
Materials and methods
We prospectively enrolled patients at a single university-affiliated tertiary referral center. Patients were eligible if they were (a) at least 18 years old, (b) mechanically ventilated for greater than 24 hours, and (c) extubated. Exclusion criteria included tracheostomy, at least 72 hours since extubation, preexisting dysphagia, history of head or neck surgery/radiation, contraindication to oral nutrition, or presence of a neurologic disease that could acutely impair swallowing. The patient or surrogate decision maker signed an informed consent form for participation. The Colorado Multiple Institutional Review Board (COMIRB Panel B, COMIRB No. 12-0184 APP001-2) approved this study.
Bedside swallowing evaluation
An SLP reviewed the patient's medical record and performed an examination, starting with the clinician's judgment of lip movement and seal, tongue movement and strength, volitional cough strength, dentition, voice quality, and amount of assistance required with feeding. The patient was seated as upright as possible. The SLP then administered 5 standard consistencies. When possible, boluses were administered from lowest to highest aspiration risk: (1) 1 tsp ice chips, (2) 1 tsp nectar-thick liquids, (3) 1 tsp pureed solids (applesauce or vanilla pudding), (4) 5 mL thin liquids (water or milk), and (5) solids (¼ graham cracker or ½ saltine). The SLP watched for 5 predefined signs of aspiration after each bolus:
Cough: a cough or choking sound within 10 seconds Throat clearing: presence of throat clearing within 10 seconds Change in vocal quality: vocal quality was dichotomized as normal/abnormal. Development of abnormal vocal quality within 10 seconds was a positive finding. Wet breath sounds: gurgling is a low/medium-pitched rattling sound on inhalation or exhalation. Development of gurgling within 10 seconds was a positive finding. Stridor: Stridor is a harsh vibrating sound on inhalation or exhalation. Development of stridor within 10 seconds was a positive finding.
Breath sounds and stridor were assessed by auscultating over the thyrocricoid space or listening to the patient's breathing without a stethoscope. If any of the 5 signs occurred, the trial of that consistency was recorded as consistent with aspiration. A decrease in pulse oximetry greater than 3% at any point during BSE was recorded. A bolus could be withheld if the SLP had safety concerns.
After the trials of varying consistencies, the SLP administered the 3-WST. The 3-WST could be withheld for safety concerns. Patients undergoing 3-WST received 3 oz of water and were instructed to drink the entire amount without interruption via cup or straw [28] [29] [30] . Criteria for a positive 3-WST were as follows: inability to drink the entire amount, cough or choking up to 1 minute afterward, or change in vocal quality. Finally, the SLP documented diet recommendations and whether instrumental testing (VFSS or FEES) was indicated.
The accuracy of the overall BSE was assessed using 2 different definitions of aspiration. The first was a more liberal definition: patients recommended any alteration in their diet, including nil per os (NPO), had a positive BSE for aspiration, and patients recommended a "normal diet" (regular solids and thin liquids) had a negative BSE. The second definition was stricter: patients recommended to be NPO had a positive BSE, and patients allowed oral intake had a negative BSE.
A second SLP or study investigator who was blinded to the BSE subsequently performed the FEES. At the discretion of the SLP/investigator, intranasal lidocaine spray could be administered before laryngoscope insertion. The SLP/investigator then administered the same 5 consistencies and amounts as on BSE. After each swallow, the laryngoscope was advanced to closely view the airway for 10 seconds before recording the results of that trial. If necessary, patients could drink water between trials to clear remaining residue. Each FEES trial was scored using the Penetration-Aspiration Scale (PAS; Table 1 [31] ). The primary outcome of FEES was presence of aspiration (PAS ≥6) on any consistency.
After enrollment, chart review was performed. Basic demographic information such as age, race, and sex were collected, as well as more specific information, including Acute Physiology and Chronic Health Evaluation II (APACHE II) score and Charlson Comorbidity Index, Confusion Assessment Method for the ICU (CAM-ICU), and Activity Measure for Post-Acute Care (AM-PAC) short-form scores. The AM-PAC is a valid and reliable instrument for assessing weakness and function. The AM-PAC basic mobility Inpatient Short Form includes 6 questions that assess how much assistance an individual requires from another person for specific tasks such as turning from the back to the side while in bed without using bedrails and moving to and from a bed to a chair. Each of the 6 questions is scored from 1 (indicating total assistance) to 4 (indicating no assistance). The overall score ranges from 6 to 24, with lower scores reflecting more disability [32, 33] .
Data were analyzed using JMP Pro (Version 12.0.1; SAS Institute Inc, Cary, NC, 2015). Paired dichotomous data were analyzed using McNemar test. Fisher exact test was used for nominal dependent variables. Ordinal dependent variables were analyzed using the Wilcoxon Table 1 Penetration-Aspiration Scale Mann-Whitney exact test. Continuous dependent variables were analyzed using logistic regression. Using FEES as the criterion standard, the positive likelihood ratio (LR) was determined for statistically significant demographic and physical examination variables. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and area under the receiver operating characteristic curve (AUC) were determined for the swallowing trials, 3-WST, and overall BSE recommendations with 95% confidence intervals (95% CIs).
Results
Of the 54 patients enrolled, 45 patients were included in the analysis. Seven patients did not complete both BSE and FEES for the following reasons: reintubated before evaluation (n = 3), refused FEES after consent (n = 2), refused both BSE and FEES (n = 1), and scheduling conflicts for FEES (n = 1). One patient was excluded for less than 24 hours on mechanical ventilation, and one due to tracheostomy. Median age was 55 years with an interquartile range (IQR) of 47 to 65 years. Median duration of mechanical ventilation was 3.3 days (IQR, 1.8-6.0). Sixty-seven percent were male. Median APACHE II score on admission was 22 (IQR, [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] . Median Charlson Comorbidity Index was 2 (IQR, 1-3). Twenty-two percent (n = 10) of the patients had chronic obstructive pulmonary disease (COPD) as judged by chart review. Fortyfour percent (n = 20) of the patients had a size 7.5 or lower endotracheal tube. Forty-one percent (n = 19) of the patients received sedating medications in the 12 hours before the swallow evaluation. Eight patients had been mechanically ventilated more than once during that admission.
Not all patients completed testing for every consistency due to safety concerns of the clinician administering the BSE or FEES. On BSE, 5 patients did not undergo trials of ice chips, 5 did not trial puree, 15 did not trial nectar-thick liquid, and 9 did not trial solids. All patients trialed thin liquids. All but one patient underwent 3-WST. Similarly, on FEES, 7 patients did not trial ice chips, 3 did not trial puree, 6 did not trial nectarthick liquid,13 did not trial solids, and 4 did not trial thin liquids. The median duration of FEES was 5.5 minutes (IQR, 3.2-7.4). The duration of BSE was not recorded.
Using PAS ≥6 on FEES examination as the criterion standard, 31% (n = 14) of the patients aspirated on at least one consistency: 5 aspirated on ice chips, 9 on thin liquids, 2 on puree, 4 on nectar-thick liquids, and 1 on solids. Age, sex, race, Charlson Comorbidity Index, COPD, use of sedating medications, and multiple episodes of mechanical ventilation before testing were not associated with aspiration (Table 2, Fig. 1 ). The following were associated with aspiration on FEES: endotracheal tube size less than 8.0 (LR = 0.9 [95% CI, 0.5-1.6], P = .028), APACHE II score (P = .007), and AM-PAC basic mobility score (P = .018).
Components The accuracy of each consistency testing for overall FEESdocumented aspiration is displayed in Table 3 . Nectar-thick liquids maintained the best sensitivity at 73% (95% CI, 43%-90%). Puree maintained the best specificity at 93% (95% CI, 77%-98%). The 3-WST had a sensitivity of 77% (95% CI, 50%-92%) and specificity of 65% (95% CI, 47%-79%). The accuracy of each consistency test for FEES-documented aspiration on that consistency is shown in Table 4 . A pulse-ox change greater than 3% during BSE was associated with aspiration on FEES (negative LR = 1.1 [95% CI, 1.0-1.2], P = .008).
Using the liberal definition of aspiration, 18 patients were recommended a normal diet after BSE, of whom 2 aspirated on FEES. Of the 27 patients recommended any altered diet after BSE, 12 aspirated on FEES. The dietary recommendation of "altered diet" had a sensitivity of 86% (95% CI, 60%-96%), specificity of 52% (95% CI, 35%-68%), PPV of 44% (95% CI, 28%-63%), NPV of 89% (95% CI, 67%-97%), and AUC of 0.69.
Using the conservative definition of aspiration, 36 patients were allowed oral intake, of whom 7 aspirated on FEES. Of the 9 patients recommended NPO, 7 aspirated on FEES. The dietary recommendation of NPO had a sensitivity of 50% (95% CI, 27%-73%), specificity of 94% (95% CI, 79%-98%), PPV of 78% (95% CI, 45%-94%), NPV of 81% (95% CI, 65%-90%), and AUC of 0.72. The SLP recommended further testing with VFSS or FEES in 9 patients (20%), which was not associated with aspiration (P = .132). 
Discussion
In this study, we evaluated the accuracy of BSE and 3-WST for detecting aspiration. Using a recommendation of altered diet after BSE as a liberal definition of aspiration generated a sensitivity of 86% and specificity of 52% when compared with a criterion standard FEES examination. Using a conservative definition of aspiration (recommendation of NPO after BSE) yielded better specificity at 94% but lower sensitivity at 50%. Prior studies of patients with stroke yielded similar results to our liberal definition when comparing a BSE to either FEES or VFSS. The sensitivity on these studies ranged from 80% to 91% and specificity from 30% to 68% [34] [35] [36] [37] . In contrast, a study in patients with a spinal cord injury reported a higher sensitivity and specificity at 100% and 93%, respectively. This study included 30 patients; more than half had a tracheostomy and were receiving mechanical ventilation [38] . In survivors of ARF, one prior study compared BSE to FEES, but patients were randomized to FEES or BSE rather than having both; 14% aspirated on FEES and 6% had a positive BSE [4] .
The 3-WST was not an accurate test for aspiration, with a sensitivity of 77% and specificity of 65%. These numbers are similar to those reported on validation of the 3-WST in stroke patients, with a sensitivity of 76% and specificity of 59% [28] . Other blinded studies in stroke patients reported higher sensitivity for the 3-WST at 86%, but lower specificity at 50% [34, 35] . One study found 3-WST to be less sensitive and more specific, at 52% and 86%, respectively, in a blinded assessment of patients with various neurologic conditions [39] . Two large studies in heterogeneous populations found a higher sensitivity of the 3-WST for aspiration, at 96.5% and greater than 98%. However, neither was blinded; the endoscopist performed 3-WST directly after FEES [30, 40] . This may have influenced the rating of the 3-WST. In one of these studies, nearly 10% of patients did not undergo 3-WST because FEES demonstrated high aspiration risk. This may have eliminated some patients at risk for silent aspiration [40] .
We found that 14% of patients who aspirated on FEES had a negative BSE. This may underestimate silent aspiration in our population, as it excludes patients who aspirated silently on one consistency but had clinical signs of aspiration on another. The 3-WST performed worse, with 23% of patients who aspirated on FEES having a negative 3-WST. Previously reported rates of postextubation silent aspiration range from 17% to 25% [2, 5, 6] . Patients with silent aspiration suffer the same complications as those with overt aspiration [10, 41, 42] . Identification and treatment for these patients can decrease clinically significant aspiration [5, 43] .
We did not find any consistency on BSE to be a good predictor of aspiration on FEES. Although puree had the highest specificity at 93%, sensitivity was low at 64%. No consistency was more than 73% sensitive for detecting overall aspiration on FEES. Abnormal trials of some of these consistencies appeared better at predicting FEES-documented aspiration on the same consistency; however, fewer patients were included in these analyses (the patients who aspirated on each consistency were a subset of the patients who aspirated overall). The low sensitivities of these trials suggest that bedside screening tests using only one consistency may be inadequate.
Our study had some limitations. We had a relatively small sample size. Because of safety concerns, some of our patients did not receive every trial bolus on BSE and FEES. The small sample size and incomplete data set may have affected the accuracy of our measured sensitivity and specificity. We may have been unable to detect some predictors of aspiration on BSE. A larger sample would allow for more sophisticated analysis to develop a screening algorithm for aspiration, as well as further investigate the associations between the components of the BSE and aspiration on FEES. One example is cough strength, a subjective measurement on BSE. Development of a standardized way of measuring cough strength after extubation is one avenue for further study. Activity Measure for Post-Acute Care scores were associated with aspiration, which may suggest that aspiration after extubation is part of a syndrome of ICU-acquired weakness. Further investigation with prospectively collected data, including Medical Research Council sum scores and possibly electrophysiological testing, may be useful.
We were unable to look for differences in outcomes such as pneumonia or mortality between FEES and BSE. Although VFSS is more widely available, we used FEES as our criterion standard instrumental examination [18] . Prior studies have demonstrated excellent agreement between VFSS and FEES as well as good interrater and intrarater reliability for both; however, FEES is more sensitive for penetration and aspiration [44] [45] [46] [47] [48] [49] . Videofluoroscopic swallow study requires transportation to fluoroscopy, which can be challenging in critically ill patients, whereas FEES can be performed at the bedside. Introducing access to FEES may increase the chance that patients will get an instrumental assessment of swallowing, despite preexisting availability of VFSS [43] . Our patients received 0.2 mL of intranasal lidocaine at the SLP's discretion. The use of topical lidocaine at this dose during FEES can improve patient comfort and does not increase the risk of penetration or aspiration [50] [51] [52] .
Conclusion
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